Pharmaceutical Industry Information Portal

HomeWorld Pharma News

World Pharma News

Hanmi Science has completed the development of six types of raw materials for mRNA vaccines

Hanmi Science has formed a consortium with ST Pharm and GC Green Cross to secure and commercialize domestic mRNA vaccine technology by 2022.

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing

The collaboration aims to provide Canadians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza...

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Following closing of the acquisition, Bayer will own full rights to Vividion’s proprietary discovery platform, which comprises three integrated, synergistic components.

EC approves contract for a potential COVID-19 vaccine with Novavax

Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses.

Sanofi acquires biotech company Translate Bio for $3.2 billion

Sanofi and Translate Bio have a shared commitment to innovation in the mRNA space.

Amgen To Acquire Privately Held Teneobio For $900 Million

The acquisition includes Teneobio's proprietary bispecific and multispecific antibody technologies, which will enable significant acceleration and efficiency in the discovery and development of new molecules.
spot_img

Expert Articles

spot_img